Innovation in drug delivery

We pioneered the autoinjector industry. Now we're pioneering what's next.

We shape the future as the innovation leader

From pioneering the autoinjector industry to redefining the future of drug delivery.

Innovation has always been at the heart of SHL Medical. From DAI, one of the industry's pioneering autoinjector platforms, to Molly, Magnitude, Reunite, and Quanta, we continue to develop technologies that address emerging therapeutic challenges and improve the patient experience. Backed by vertically integrated manufacturing, proprietary automation, and a commitment to sustainability, we transform bold ideas into scalable solutions that help shape the future of self-injection.

Three dimensions of innovation- product, manufacturing, and sustainability- enable SHL Medical to continue advancing the future of drug delivery while staying true to our purpose: enabling patients' independence.

[.jpg] PFS & IDD East Coast 2026 DSC06530 — Quanta, our newest product innovation

Innovation comes in many forms at SHL

Innovation extends beyond product development.

At SHL Medical, innovation takes many forms. It is reflected in the technologies we develop, the manufacturing capabilities we continuously advance, and the sustainable practices we integrate across our operations. It is also demonstrated through our thought leadership, industry collaborations, and contributions to conversations shaping the future of drug delivery. Together, these efforts help address evolving healthcare challenges while creating greater value for patients, partners, and the wider industry.

Product innovation

We develop technologies that expand the possibilities of self-injection. From autoinjector platforms like Molly and Magnitude to our automated reconstitution system, Reunite, and multi-fixed-dose delivery system, Quanta, our innovations support evolving therapies while simplifying patient treatment. By combining deep engineering expertise with a clear understanding of user needs, we help pharmaceutical partners bring differentiated combination products to market.

Manufacturing innovation

Innovation does not end with device design. Our vertically integrated manufacturing model enables us to industrialize innovation at scale. Through in-house molding, proprietary automation, integrated testing, and a global manufacturing network, we maintain control over critical processes while supporting reliable, high-volume production. This enables a seamless path from development to commercialization and helps ensure long-term supply for patients worldwide.

Sustainability innovation

We believe innovation should deliver value beyond the device itself. We embed sustainability considerations throughout our development and manufacturing processes, from responsible material selection and bio-circular plastics to optimized packaging, logistics, and design choices that reduce environmental impact. By integrating sustainability into how we innovate, we help create solutions that benefit patients, partners, and the planet.

Innovation showcase: Quanta

Performance that repeats.
Quanta illustrates SHL Medical's approach to innovation across product design, manufacturing, and sustainability. Created for the emerging demands of cardiometabolic therapies, it reimagines the pen injector experience through simplified handling, fixed-dose confidence, and a scalable multi-dose platform. At the same time, its design improves efficiency across manufacturing, packaging, and logistics while incorporating bio-circular materials to reduce environmental impact. Together, these innovations demonstrate how SHL Medical continues to shape the future of drug delivery through integrated, patient-centric solution

Learn more about Quanta

[.psd] Quanta 2 devices 2uncap (3 Angles Attached)

Innovation showcase: Elexy

Innovation is about anticipating tomorrow's therapeutic challenges before they emerge. Elexy was created with that mindset.

As SHL Medical's first electromechanical autoinjector platform, Elexy showcases how we are exploring the future of self-injection. Built around three innovation pillars- versatility, reusability, and connectivity- Elexy combines a flexible architecture that supports diverse therapy requirements, a reusable power unit designed with sustainability in mind, and connected capabilities that enable richer treatment insights.

Together, these innovations demonstrate how SHL Medical is reimagining the next generation of drug delivery technologies and shaping the future of healthcare.

Elexy on Table PFS+CART - Molly and Maggie

Our legacy and breadth of expertise

For more than 35 years, SHL Medical has turned expertise into innovation. By combining capabilities across design, engineering, automation, manufacturing, and commercialization, we have continuously expanded the possibilities of drug delivery. This breadth of expertise enables us to pioneer new technologies, bring innovative solutions to market, and help shape the future of self-injection.

Read more about our breadth of expertise

Redefining what's possible in self-injection

The next generation of biologics is challenging traditional approaches to drug delivery. SHL Medical is exploring innovative solutions for large-volume and high-viscosity therapies, combining advanced delivery technologies with patient-centered design. These developments aim to expand the possibilities of self-administration and support future treatments across a wide range of therapeutic areas, including oncology.

Get in touch